SUMMARY Copper, caeruloplasmin, transferrin, albumin, and total protein were measured in the serum and synovial fluid of 40 patients with rheumatoid arthritis and 40 patients with osteoarthrosis. A raised synovial fluid copper and caeruloplasmin have been found to be characteristic of rheumatoid effusions. The relation between copper and caeruloplasmin in synovial fluid differs from that in serum. Synovial fluid caeruloplasmin was increased disproportionately in relation to other plasma proteins present in rheumatoid effusions.
In the light of accumulating evidence pointing to an abnormal copper and caeruloplasmin metabolism in rheumatoid arthritis (RA) (Scudder et al., 1978) we decided to study copper levels and reJated variables in the synovial fluid of RA patients and a control group of patients with degenerative arthritis. Synovial fluid findings were also related to serum levels and the serum/synovial fluid partition of different proteins was calculated.
Material
Synovial fluid and blood were collected from 40 patients with RA (33 females, 7 males) and from a control group of 40 patients with osteoarthrosis (24 females, 16 males). The RA patients were being treated with conventional analgesic and antiinflammatory drugs (salicylates, ibuprofen, and indomethacin Transferrin and caeruloplasmin were estimated by single radial immunodiffusion (Mancini et al., 1965) . Commercially prepared M-Partigen immunodiffusion plates and lyophilised protein standards were obtained from Hoechst Pharmaceuticals, Hounslow, UK. Non-caeruloplasmin-bound copper was calculated as the difference between total and caeruloplasmin-bound copper. Caeruloplasmin-bound copper was calculated assuming that the copper content w/w of caeruloplasmin is 0.32% (Kasper and Deutsch, 1963) .
Results
Copper and caeruloplasmin were significantly increased (P<0-01) in the RA group compared with the osteoarthrotic group. There was a strong positive correlation between synovial fluid copper. ,umol/l (22.48±0.6 ,ug/100 ml). In the rheumatoid group there was a calculated copper 'deficit' in terms of the caeruloplasmin detected immunologically. In other words, in rheumatoid synovial fluids copper was insufficient to account for all the caeruloplasmin measured.
TOTAL PROTEIN ALBUMIN AND TRANSFERRIN
The mean total protein content of rheumatoid synovial fluid was significantly higher (P<0-02) than that of osteoarthrotic fluid. Mean levels of synovial fluid albumin and transferrin were not significantly different. The partition ratio for caeruloplasmin in the osteoarthrotic group was 0-42 while in the RA group it was 0-69. These results are summarised in Table 2 .
Discussion
The permeability of synovial membrane to plasma proteins is poorly understood. It is a highly selective process which probably depends on molecular size, molecular weight, and metabolic changes in the joint as well as on the plasma concentration of different proteins. Damage to or destruction of the membrane will result in loss of its ability to selectively limit or exclude certain plasma proteins. The changes induced by acute or subacute inflammation may be superimposed on this pattern. Our results show that a raised synovial fluid caeruloplasmin is characteristic of rheumatoid, as distinct from osteoarthrotic, effusions. This difference, moreover, is considerably greater than the difference between total protein concentrations; and caeruloplasmin concentration in relation to total protein concentration is higher in rheumatoid synovial fluid than in rheumatoid serum. Whether similar changes occur in other inflammatory effusions remains to be established. The rise in synovial fluid caeruloplasmin (as in serum caeruloplasmin) may be related to the protein's powerful antioxidant action (Al-Timimi and Dormandy, 1977 
